“…Exogenous SRIF also inhibits basal plasma GH concentrations in chickens and ducks (Strosser, Harvey, Foltzer & Mialhe, 1984;Foltzer, Strosser, Harvey & Mialhe, 1985;Harvey & Scanes, 1987;Scanes & Harvey, 1989) and blocks the in-vivo (Harvey & Scanes, 1987;Scanes & Harvey, 1989) and in-vitro (Perez, Malamed & Scanes, 1987;Foltzer-Jourdainne, Har¬ vey & Mialhe, 1988) GH response to GH-releasing factor or thyrotrophin-releasing hormone (TRH). These effects are likely to be mediated by specific SRIF receptors on pituitary somatotrophs, as ob¬ served on tumorous somatotrophs (Schonbrunn 8c Tashjian, 1980; Moyse, Le Dafniet, Epelbaum et al 1985) and healthy pituitary tissue (Leitner, Rifkin, Maman & Sussman, 1979;Srikant & Patel, 1982; Lewis & Williams, 1987) in mammals.…”